drugset

drugset / Trial / NCT06488755

SIM0718 Treatment of Asthma Clinical Study

NCT06488755 ↗

Phase 3 Recruiting 418 enrolled Simcere Pharmaceutical Co., Ltd

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase III clinical study of SIM0718 asthma

Timeline

Start: 2024-06-23
Primary completion: 2027-02-28
Completion: 2027-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SIM0718	Unknown	300 mg	Subcutaneous

Indications